Non-invasive lung testing in asthma and cystic fibrosis
Part of Digestive system, Genetic & congenital, Immune system & allergy, Lungs & breathing clinical trials.
This trial studies how well a non-invasive lung test can show lung involvement in people with asthma (especially IgE-related asthma) and people with cystic fibrosis. You might benefit by getting extra lung assessments without invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate asthma, or asthma related to an allergy marker called IgE
- You have cystic fibrosis (if you’re in the cystic fibrosis group)
- If you’re a healthy control, you must not have any lung disease
- You must be a child or adult (the trial includes both ages)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple breath test to detect different lung diseases. By analyzing the chemicals in your breath, researchers hope to find a faster, non-invasive way to diagnose lung conditions. It may be an option if you have a known lung disease and have a recent CT scan.
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
This trial looks for early, “hidden” breathing test abnormalities in people with cystic fibrosis who have normal routine lung test results. It may help researchers find blockage in smaller airways before it shows up on standard tests.
This trial uses a special breathing MRI (you breathe a gas mixture) to measure how well your lungs work. It studies healthy kids and people with lung conditions like cystic fibrosis or asthma, and it may help researchers better understand lung function and flare-ups.
This study is checking if a blood test for procalcitonin (a sign of infection) can help measure how severe bronchiectasis is in children. It aims to find a way to better understand and manage this lung condition.
This study is testing a new way to diagnose asthma in children and teens using simple breathing tests. If your regular breathing test wasn't clear, this might give a more accurate answer.
Hear when a new Bronchial Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.